Author(s): Retno Lestari, Ah Yusuf, Rachmat Hargono, Ahsan Ahsan


DOI: 10.5958/0974-360X.2020.00890.2   

Address: Retno Lestari1,3*, Ah Yusuf2, Rachmat Hargono3, Ahsan Ahsan1
1Study Program of Nursing Science, Faculty of Medicine, University of Brawijaya, Malang, Indonesia.
2Faculty of Nursing, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
3Doctoral Program of Public Health, Faculty of Public Health, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
*Corresponding Author

Published In:   Volume - 13,      Issue - 11,     Year - 2020

Addressing medication adherence among schizophrenic patients has been a complicated process that requires multifactorial solutions. Some aspects of non-adherence were caused by sociocultural issues, financial problems, stigma, care fragmentation, and poor insight. Medication non-adherence can lead to exacerbation of symptoms, higher rates of relapse and increased use of health services. Medication and psychotherapies were known to be an effective treatment for schizophrenia, but these did not resolve the underlying causes of the illness. Involving the community support systems, in addition to medical treatment can improve adherence to treatment. At this stage, there is little available information on the topic of the community-based models for supporting medication adherence in schizophrenic patients. The objective of this study was to explore a community resilience model as a new way of optimizing medication adherence among schizophrenic patients. A systematic review was written based on 99 data sources: Science Direct, Google Scholar, Proquest Health and Medical Complete, Proquest Psychology Journals and Proquest Science Journals from 2006 to 2019. There were only 15 articles eligible to be reviewed. The essential components of the community resilience model have been shown as an effective method for supporting medication adherence in several studies. Engaging communities to support each other, coping with emotional, social and the pressures of daily life can foster greater community resilience. The underlying principles for community resilience are focused on getting stronger, helping others, being socially organized, keeping connected, learning to reflect and share ideas, being locally interdependent and reasonably profitable. These findings could potentially inform the development of the community resilience model for optimizing medication adherence among schizophrenic patients.

Cite this article:
Retno Lestari, Ah Yusuf, Rachmat Hargono, Ahsan Ahsan. A Community-Resilience Model: A New Way in Optimizing Medication Adherence among Schizophrenic Patients. Research J. Pharm. and Tech. 2020; 13(11):5083-5087. doi: 10.5958/0974-360X.2020.00890.2

Retno Lestari, Ah Yusuf, Rachmat Hargono, Ahsan Ahsan. A Community-Resilience Model: A New Way in Optimizing Medication Adherence among Schizophrenic Patients. Research J. Pharm. and Tech. 2020; 13(11):5083-5087. doi: 10.5958/0974-360X.2020.00890.2   Available on:

1.    Archana S, Ram M. A Prospective Study on Assessment of Medication Adherence of Patients Towards Antihypersentive Medications. Research J. Pharm. and Tech. 2017; 10(11): 3779-3782.
2.    Teferra S, et al. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry. 2013; 13(1): 168.
3.    Vassileva IV, Milanova VK. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia. Folia Medica. 2012; 54(4): 62-68.
4.    Vassileva I, et al. Predictors of Medication Non-adherence in Bulgarian Outpatients with Schizophrenia. Community Ment Health J. 2014; 50: 854–861.
5.    Haddad PM, et al. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Related Outcome Measures. 2014; 5: 43–62.
6.    Girma E, et al. Public Stigma against People with Mental Illness in the Gilgel Gibe Field Research Center (GGFRC) in Southwest Ethiopia. PLoS One. 2013; 8(12): e82116.
7.    Panchal II, et al. Schizophrenia: Treatment and Future aspects: a Systemic Review. Asian J. Research Chem. 2012; 5(12): 1503-1512.
8.    Beygi N, et al. Treatment adherence and its determinant factors amongst outpatients with Hypertension: A Case of Iran. International Journal of Nursing Education and Research. 2017; 5(3): 287-292.
9.    Abinaya SK, Vijey Aanandhi M. An Improvement in Patient Compliance in Diabetes Mellitus. Research J. Pharm. and Tech. 2018; 11(2):587-592.
10.    Pratt Si, et al. Medication nonadherence in older people with serious mental illness: prevalence and correlates. Psychiatric Rehabilitation Journal. 2006; 29(4): 299-310.
11.    Noor Us Saba Z, et al. Medication adherence in schizophrenia: Understanding patient’s views. National Journal of Physiology, Pharmacy and Pharmacology. 2019; 9(5): 373-378.
12.    Adelufosi AO, et al. Medication adherence and quality of life among Nigerian outpatients with schizophrenia. General Hospital Psychiatry. 2012; 34(1): 72–79.
13.    Chacko A, et al. Assessment of Adherence of COPD Patients to Respiratory drug Therapy in a Tertiary care Hospital in Mangalore. Asian J. Nursing Edu. and Research. 2015; 5(1): 35-37.
14.    Farooq S, Naeem F. Tackling nonadherence in psychiatric disorders: current opinion. Neuropsychiatric Disease and Treatment. 2014; 10: 1069–1077.
15.    Fatima J, et al. Patient Medication Adherence and the Health Outcome. Asian Journal of Pharmaceutical Research. 2018; 8(2): 78-82.
16.    Islahudin F, et al. Medication Adherence and Satisfaction among Patients in Malaysia. Research J. Pharm. and Tech. 2019; 12(3): 1051-1054.
17.    King D, et al. The impact of non-adherence to medication in patients with schizophrenia on health, social care and societal costs. Analysis of the QUATRO study. Epidemiology and Psychiatric Sciences. 2014; 23: 61–70.
18.    Velligan DI, et al. The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia. Schizophrenia Bulletin. 2008; 34(3): 483–493.
19.    Asher L, et al. Community-based psychosocial interventions for people with schizophrenia in low and middle-income countries: systematic review and meta-analysis. BMC Psychiatry. 2017; 17(1): 355.
20.    Tan HJR. When all else fails: supervised treatment in outpatient for schizophrenia (STOPS). BMJ Case Rep. 2017. Available from: URL: https://doi/org/10.1136/bcr-2017-221518.
21.    Bressington D, et al. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: A cross sectional study. International Journal of Mental Health Nursing. 2012; 22(1): 35–46.
22.    Wang X, et al. Adherence to Antipsychotic Medication by Community-Based Patients with Schizophrenia in China: A Cross-Sectional Study. Psychiatric Services. 2016; 67(4): 431–437.
23.    Stentzel U, et al. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry. 2018; 18: 155.
24.    Nath K. Medication Compliance Status among Psychiatric Patients Attending the Psychiatry Department of Guwahati Medical College and Hospital, Guwahati, Assam. Asian J. Nursing Edu. and Research. 2017; 7(3): 289-294.
25.    Hsieh WL, et al. Mediating Effect of The Motivation for Medication Use on Disease Management and Medication Adherence Among Community-Dwelling Patients with Schizophrenia. Patient Preference and Adherence. 2019; 13: 1877–1887.
26.    Tsang HWH, et al. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia. Journal of Behavior Therapy and Experimental Psychiatry. 2009; 40: 3-14.
27.    Macaluso M, McKnight S. Overcoming medication nonadherence in schizophrenia: strategies that can reduce harm. Current Psychiatry. 2013; 12(11): 15-20.
28.    Parihar VK. Perception Regarding Mental Illness in a Rural Community in Rajasthan: A Community based Study. International Journal of Nursing Education and Research. 2018; 6(1): 47-58.
29.    Janarthanan B, et al. Insight and Attitude towards drug intake: Risk factors for relapse in patients with psychosis - A pilot study report. International Journal of Nursing Education and Research. 2016; 4(3): 348-352.
30.    Wilk JE, et al. Family Contact and the Management of Medication Non-adherence in Schizophrenia. Community Ment Health J. 2008; 44: 377–380.
31.    Beebe LH. What Community Living Problems Do Persons with Schizophrenia Report During Periods of Stability? Perspectives in Psychiatric Care. 2010; 46(1): 48–55.
32.    Kim J-I, et al. Effects of a Peer-Delivered Health-Promoting Exercise Program for Community-Dwelling Elders. Research J. Pharm. and Tech. 2017; 10(9): 3069-3073.
33.    Balasubramanian N, et al. An Evaluative Study of Video Assisted Teaching Module (VATM) on Homecare of Schizophrenic Patients developed for Primary Caregivers at Mangaluru. Asian J. Nursing Edu. and Research. 2017; 7(1): 53-60.
34.    Norris FH, et al. Community Resilience as a Metaphor, Theory, Set of Capacities, and Strategy for Disaster Readiness. Am J Community Psychol. 2008; 41: 127–150.
35.    Pfefferbaum RL, et al. The Communities Advancing Resilience Toolkit (CART): An Intervention to Build Community Resilience to Disasters. J Public Health Management Practice. 2013; 19(3): 250–258.
36.    Yates TM, et al. Resilience Theory and the Practice of Positive Psychology from Individuals to Societies. In Positive Psychology in Practice: Promoting Human Flourishing in Work, Health, Education, and Everyday Life. Wiley. 2015; 2nd edition: p. 773-788.
37.    Cabell JF, Oelofse M. An Indicator Framework for Assessing Agroecosystem Resilience. Ecology and Society. 2012; 17(1): 18.
38.    Cechnicki A, Wojciechowska A. Correlations between parameters of the social network and treatment outcomes of people suffering from schizophrenia seven years after the first hospitalization. Archives of Psychiatry and Psychotherapy. 2008; 2: 21–29.
39.    El-Mallakh P, Findlay J. Strategies to improve medication adherence in patients with schizophrenia: the role of support services. Neuropsychiatric Disease and Treatment. 2015; 11: 1077–1090.
40.    Rabinovitch M, et al. The Influence of Perceived Social Support on Medication Adherence in First-Episode Psychosis. The Canadian Journal of Psychiatry. 2013; 58(1): 59–65.
41.    Srinivasan G, Khakha DC. Does Perceived Social Support and Insight Influence Schizophrenic Patients Medication Adherence? Research and Reviews: Journal of Neuroscience. 2018; 8(3): 12-18.
42.    Torgalsbøen A-K. Sustaining Full Recovery in Schizophrenia after 15 Years: Does Resilience Matter? Clinical schizophrenia and related psychoses. 2012; 5: 193-200.
43.    Meenakshi, et al. Family Resilience and Perceived Social Support among care givers of Children with Autistic Spectrum Disorder. Asian Journal of Nursing Education and Research. 2018; 8(1): 51-56.
44.    Meneghel I, et al. Feeling Good Makes Us Stronger: How Team Resilience Mediates the Effect of Positive Emotions on Team Performance. Journal of Happiness Studies. 2014; 17(1): 239–255.
45.    Lietz CA. Empathic Action and Family Resilience: A Narrative Examination of the Benefits of Helping Others. Journal of Social Service Research. 2011; 37(3): 254–265.
46.    Cinner JE, Barnes ML. Social Dimensions of Resilience in Social-Ecological Systems. One Earth. 2019; 1(1): 51–56.
47.    Orleans Reed S, et al. “Shared learning” for building urban climate resilience – experiences from Asian cities. Environment and Urbanization. 2013; 25(2): 393–412.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available